This 2019 study examined skeletal muscle from lean and obese, insulin-resistant adults and found that obesity was associated with reduced production of β-F1-ATPase, a key component of mitochondrial ATP synthase, as well as lower ATP synthase activity. The authors describe these changes as an impairment that reduces the muscle’s capacity to generate ATP.

But there is another way to interpret the finding. The authors themselves note that impaired ATP synthase function may alter reactive oxygen species (ROS) production, although this study did not measure ROS or establish why ATP synthase was downregulated. In the setting of chronic metabolic stress, reduced ATP production could therefore be viewed not simply as broken mitochondrial machinery, but potentially as an adaptive response that limits metabolic damage. The tradeoff is reduced capacity to produce ATP—and ultimately less capacity to perform physical work.

Viewed this way, the study highlights an important distinction: what looks like mitochondrial dysfunction when ATP output is the benchmark may also represent the cell defending itself against an unhealthy metabolic environment. The defense may help the cell survive, but it comes at the cost of the energetic capacity required for optimal function and health.